glp 1 discovery JCI History of glucagon-like peptide-1 receptor

Clinical trials did not identify back pain occurring at significantly higher rates compared to placebo

18 Nevertheless, the 2018 ADA Standards of Care lists alogliptin as having a potential HF risk

The dual-action of both soluble and insoluble fiber helps maintain regularity while also supporting healthy blood sugar levelsa perfect complement to the effects of GLP-1 medications

All of these different things can lower the side effects."

Medically reviewed by Dr Sultan Linjawi, Endocrinologist & Diabetes Specialist January 2026 Subscribe to Receive One of Our Helpful Free Guides Click the guide that would be the most useful What is Rybelsus (oral Semaglutide)

What Are the Real Risks of HRT in 2026